Efficacy of orally available selective melanocortin-4 receptor antagonists in a murine model of cancer cachexia

被引：0
|
作者：
Dallmann, R. [1 ]
Weyermann, P. [1 ]
Magyar, J. P. [1 ]
Anklin, C. [1 ]
Hufschmid, M. [1 ]
Nordhoff, S. [1 ]
Henneboehle, M. [1 ]
Dubach-Powell, J. [1 ]
Courdier-Fruh, I. [1 ]
Mondadori, C. [1 ]
机构：
[1] Santhera Pharmaceut Switzerland Ltd, Liestal, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20668
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice
    Weyermann, Philipp
    Dallmann, Robert
    Magyar, Josef
    Anklin, Corinne
    Hufschmid, Martina
    Dubach-Powell, Judith
    Courdier-Fruh, Isabelle
    Henneboehle, Marco
    Nordhoff, Sonja
    Mondadori, Cesare
    PLOS ONE, 2009, 4 (03):
  • [2] Discovery and in vivo efficacy of a novel, selective, and orally bioavailable Melanocortin-4 receptor antagonist for the treatment of cancer cachexia
    Weyermann, Philipp
    Bolliger, Reto
    Deppe, Holger
    Henneboehle, Marco
    Herzner, Holger
    Kervennic, Stephane
    LeGall, Audrey
    Metz, Guenther
    Nordhoff, Sonja
    Rummey, Christian
    Siendt, Herve
    Soeberdt, Michael
    Terinek, Miroslav
    Anklin, Corinne
    Cardel, Bettina
    Courdier-Fruh, Isabelle
    Dallmann, Robert
    Dubach-Powell, Judith
    Hufschmid, Martina
    Magyar, Josef P.
    Santos, Gesa
    Schaerer, Florian
    Feurer, Achim
    Mondadori, Cesare
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [3] Melanocortin-4 receptor antagonists as potential therapeutics in the treatment of cachexia
    Foster, Alan C.
    Chen, Chen
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (11) : 1131 - 1136
  • [4] Synthesis and evaluation of a novel, potent and selective, orally bioavailable melanocortin-4 receptor antagonist for the treatment of cancer cachexia
    Soeberdt, Michael
    Abel, Ulrich
    Bolliger, Reto
    Deppe, Holger
    Feurer, Achim
    Henneboehle, Marco
    Herzner, Holger
    Hoffmann-Enger, Barbara
    Kervennic, Stephane
    Le Gall, Audrey
    Metz, Guenther
    Nordhoff, Sonja
    Ott, Inge
    Rummey, Christian
    Siendt, Herve
    Terinek, Miroslav
    Weyermann, Philipp
    Anklin, Corinne
    Cardel, Bettina
    Courdier-Fruh, Isabelle
    Dallmann, Robert
    Dubach-Powell, Judith
    Hufschmid, Martina
    Magyar, Josef P.
    Santos, Gesa
    Schaerer, Florian
    Mondadori, Cesare
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [5] Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor
    Pontillo, J
    Tran, JA
    Fleck, BA
    Marinkovic, D
    Arellano, M
    Tucci, FC
    Lanier, M
    Nelson, J
    Parker, J
    Saunders, J
    Murphy, B
    Foster, AC
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (22) : 5605 - 5609
  • [6] Design, synthesis and characterization of potent and selective melanocortin-4 receptor antagonists
    Chen, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2660 - U2660
  • [7] Anticatabolic properties of melanocortin-4 receptor antagonists
    Madison, Lisa D.
    Marks, Daniel L.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2006, 9 (03): : 196 - 200
  • [8] Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor
    Jiang, Wanlong
    Tucci, Fabio C.
    Chen, Caroline W.
    Arellano, Melissa
    Tran, Joe A.
    White, Nicole S.
    Marinkovic, Dragan
    Pontillo, Joseph
    Fleck, Beth A.
    Wen, Jenny
    Saunders, John
    Madan, Ajay
    Foster, Alan C.
    Chen, Chen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4674 - 4678
  • [9] Discovery and optimization of novel 4,4-disubstituted piperidine derivatives as potent and selective melanocortin-4 receptor antagonists for the treatment of cancer cachexia.
    Soeberdt, M
    Bolliger, R
    Dunant, P
    Henneböhle, M
    Hofbauer, K
    Leuzinger, S
    Magyar, J
    Nicholson, J
    Schärer, F
    Schnüriger, F
    Stebler, M
    von Sprecher, A
    Weyermann, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U109 - U109
  • [10] The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
    Dallmann, R.
    Weyermann, P.
    Anklin, C.
    Boroff, M.
    Bray-French, K.
    Cardel, B.
    Courdier-Fruh, I.
    Deppe, H.
    Dubach-Powell, J.
    Erb, M.
    Haefeli, R. H.
    Henneboehle, M.
    Herzner, H.
    Hufschmid, M.
    Marks, D. L.
    Nordhoff, S.
    Papp, M.
    Rummey, C.
    Santos, G.
    Schaerer, F.
    Siendt, H.
    Soeberdt, M.
    Sumanovski, L. T.
    Terinek, M.
    Mondadori, C.
    Gueven, N.
    Feurer, A.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2011, 2 (03) : 163 - 174
12345